- Home
- SOLV vs FMS Comparison
SOLV vs FMS Comparison
Compare SOLV & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOLV
- FMS
- Stock Information
- Founded
- SOLV 2023
- FMS 1996
- Country
- SOLV United States
- FMS Germany
- Employees
- SOLV N/A
- FMS N/A
- Industry
- SOLV
- FMS Misc Health and Biotechnology Services
- Sector
- SOLV
- FMS Health Care
- Exchange
- SOLV NYSE
- FMS Nasdaq
- Market Cap
- SOLV 12.1B
- FMS 14.1B
- IPO Year
- SOLV N/A
- FMS 1996
- Fundamental
- Price
- SOLV $67.10
- FMS $23.11
- Analyst Decision
- SOLV Hold
- FMS Hold
- Analyst Count
- SOLV 10
- FMS 1
- Target Price
- SOLV $68.29
- FMS $23.00
- AVG Volume (30 Days)
- SOLV 801.9K
- FMS 214.6K
- Earning Date
- SOLV 12-24-2024
- FMS 11-05-2024
- Dividend Yield
- SOLV N/A
- FMS 2.69%
- EPS Growth
- SOLV N/A
- FMS 46.47
- EPS
- SOLV 4.16
- FMS 2.50
- Revenue
- SOLV $8,215,000,000.00
- FMS $21,457,738,113.00
- Revenue This Year
- SOLV $2.44
- FMS $0.24
- Revenue Next Year
- SOLV $0.38
- FMS $3.41
- P/E Ratio
- SOLV $16.64
- FMS $19.12
- Revenue Growth
- SOLV 0.60
- FMS N/A
- 52 Week Low
- SOLV $47.16
- FMS $17.93
- 52 Week High
- SOLV $77.17
- FMS $24.31
- Technical
- Relative Strength Index (RSI)
- SOLV N/A
- FMS 62.61
- Support Level
- SOLV N/A
- FMS $23.54
- Resistance Level
- SOLV N/A
- FMS $24.07
- Average True Range (ATR)
- SOLV 0.00
- FMS 0.27
- MACD
- SOLV 0.00
- FMS -0.05
- Stochastic Oscillator
- SOLV 0.00
- FMS 72.58
About SOLV SOLVENTUM CORP
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.